Literature DB >> 6861819

A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma.

C Anderström, S Johansson, S Nilsson, B Unsgaard, L Wahlqvist.   

Abstract

Prognosis was studied in 44 patients with urothelial bladder tumors, WHO grades 2 or 3, invading the lamina propria or the muscular coat, without signs of distant metastases. The patients were preoperatively randomized into two groups according to treatment: total cystectomy with or without preoperative irradiation. The 3- and 5-year survival rates were 81 and 61%, respectively, in 22 patients not receiving preoperative irradiation. 22 patients preoperatively irradiated had 3- and 5-year survival rates of 81 and 75%, respectively. Individuals who were tumor-free at cystectomy after preoperative irradiation had an excellent prognosis and tumor eradication was achieved in 80% when a cumulative radiation effect (CRE) above 1,400 reu was administered. Only 1 of 10 patients who received a CRE above 1,400 reu died from bladder tumor. This might indicate that preoperative irradiation improves the survival rate providing the CRE exceeds 1,400 reu. The presence of residual tumor after transurethral resection, aimed at resecting the tumor completely, seems difficult to evaluate since the surgeon was mistaken in believing the excision to be radical in more than 50% of the cases. The risk of error was especially high when the tumor infiltrated the muscular wall of the bladder.

Entities:  

Mesh:

Year:  1983        PMID: 6861819     DOI: 10.1159/000474069

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

Review 1.  Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.

Authors:  Kristen Mcalpine; Dean A Fergusson; Rodney H Breau; Luke F Reynolds; Risa Shorr; Scott C Morgan; Libni Eapen; Ilias Cagiannos; Chris Morash; Luke T Lavallée
Journal:  Can Urol Assoc J       Date:  2018-05-28       Impact factor: 1.862

Review 2.  Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?

Authors:  Paul Sargos; Brian C Baumann; Libni J Eapen; Amit Bahl; Vedang Murthy; Guilhem Roubaud; Mathieu Orré; Jason A Efstathiou; Shahrokh Shariat; Stephane Larré; Pierre Richaud; John P Christodouleas
Journal:  Transl Androl Urol       Date:  2016-10

Review 3.  Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d'Urologie.

Authors:  Paul Sargos; Stéphane Supiot; Gilles Créhange; Gaëlle Fromont-Hankard; Eric Barret; Jean-Baptiste Beauval; Laurent Brureau; Charles Dariane; Gaëlle Fiard; Mathieu Gauthé; Romain Mathieu; Guilhem Roubaud; Alain Ruffion; Raphaële Renard-Penna; Yann Neuzillet; Morgan Rouprêt; Guillaume Ploussard
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

4.  Treatment of locally advanced and metastatic bladder cancer.

Authors:  Makarand V Khochikar
Journal:  Indian J Urol       Date:  2008-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.